Gamida Cell Ltd. - Ordinary Shares (GMDA): Price and Financial Metrics
Today's Latest Price: $5.66 USD
Oct 22 4:00pm Add GMDA to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
GMDA Price/Volume Stats
Gamida Cell Ltd. - Ordinary Shares (GMDA) Company Bio
Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.
GMDA Latest News Stream
All News Types
Loading, please wait...
Latest GMDA News From Around the Web
Below are the latest news stories about Gamida Cell Ltd that investors may wish to consider to help them evaluate GMDA as an investment opportunity.
Gamida Cell (GMDA): Q2 GAAP EPS of -$0.69 misses by $0.39.Cash and cash equivalents of $88.6MPress Release...
Gamida Cell (GMDA) will provide updates on its pipeline candidates when it releases second-quarter 2020 results.
Gamida Cell announced the appointment of Michele Korfin as chief operating and chief commercial officer.
Is (GMDA) Outperforming Other Medical Stocks This Year?
Gamida Cell announced that David Fox has been appointed to its board of directors as an independent member.
Read More 'GMDA' Stories Here
GMDA Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.6692 seconds.